Varro Receives $20 Million from Vitalik Buterin
Summary
Varro Receives $20 Million from Vitalik Buterin to Support Development of Cutting-Edge Pathogen Biosensor TechnologyVarro to enable improved pathogen detection worldwide by making its proprietary biosensor tech platform available via Open SourceNEW YORK, ST. LOUIS and SINGAPORE October 31, 2024 Varro Holdings, Inc. (Varro), an emerging leader in products that disrupt the transmission of infectious disease, today announced it has entered into an agreement with Vitalik Buterin to receive 20 million USDC (equal to $20 million) in non-dilutive financial support for the development of its novel pathogen detection technology, and to make the technology available via open source. Our partnership with Kanro and our open-sourcing of the technology has the potential to transform global public health by changing the face of infectious disease management and enabling innovation. We are proud to share Vitaliks vision of decentralized healthcare and pandemic preparedness.Vitalik Buterin said, Im pleased to support a free and open-source hardware (FOSH) business that will both develop crucial tools for preventing the next pandemic, as well as pioneer a new paradigm of free and open-source hardware development that can enable widely distributed access to tools for personal health and beyond. Founded in 2020 as Y2X Life Sciences, the companys vision is to ensure and enable healthy environments and to prevent future pandemics and disease outbreaks. Marcus Terentius Varro (116-27 BC) was an ancient Roman scholar whose work anticipated the sciences of microbiology and epidemiology.For more information, visit varrobio.com and connect with the company on LinkedIn.Vitalik Buterin is co-founder of Ethereum.